CHIMERIC ANTIGEN RECEPTOR T CELLS DERIVED FROM IMMUNOENGINEERED PLURIPOTENT STEM CELLS
The invention provides universally acceptable "off-the-shelf" hypoimmune pluripotent (HIP) cells and hypoimmune chimeric antigen receptor T (CAR-T) cells derived from the HIP cells. The engineered therapeutic cells can be administered to subjects as an adoptive cell-based immunotherapy to...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
09.04.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!